Risk stratification of patients after myocardial revascularization by stress Tc-99m tetrofosmin myocardial perfusion tomography

被引:15
|
作者
Elhendy, A
Schinkel, AFL
van Domburg, RT
Bax, JJ
Valkema, R
Poldermans, D
机构
[1] Erasmus MC, Thoraxctr, Rotterdam, Netherlands
[2] Erasmus MC, Dept Nucl Med, Rotterdam, Netherlands
[3] Leiden Univ Hosp, Leiden, Netherlands
[4] Univ Nebraska, Div Cardiol, Dept Internal Med, Omaha, NE USA
[5] Univ Nebraska, Med Ctr, Omaha, NE USA
关键词
prognosis; stress testing; myocardial revascularization; myocardial perfusion imaging; technetium 99m tetrofosmin;
D O I
10.1016/S1071-3581(03)00651-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The aim of this study was to assess the incremental prognostic value of stress technetium 99m tetrofosmin imaging after myocardial revascularization. Methods and Results. We studied 381 patients (aged 60 ± 10 years, 270 men), 4.5 ± 3.2 years after myocardial revascularization (coronary artery bypass grafting in 201 patients and percutaneous coronary intervention in 180 patients), who underwent exercise or dobutamine stress tetrofosmin single photon emission computed tomography. Events during a mean follow-up period of 3.5 ± 1.4 years were cardiac death in 22 patients, nonfatal myocardial infarction in 11 patients (33 hard cardiac events), and late revascularization in 50 patients. There was no incidence of hard cardiac events in the 100 patients with normal perfusion. Hard cardiac events occurred in 19% of patients with reversible perfusion abnormalities and in 4% of patients without them (P < .01). The incidence of hard cardiac events was similar in patients with and without angina before stress testing (17/197 [8.6%] vs 16/184 [8.7%]). In a multivariate analysis model, predictors of cardiac death were stress rate pressure product and abnormal perfusion. Reversible perfusion abnormalities were independently associated with the composite endpoints of cardiac death, nonfatal myocardial infarction, and late revascularization. In an incremental multivariate analysis model, an abnormal scan was additive to clinical data in the prediction of hard cardiac events (model X2 = 17 vs 11, P < .01). Conclusion. Stress Tc-99m tetrofosmin myocardial perfusion imaging provides independent prognostic information for the prediction of cardiac events after myocardial revascularization. Symptoms are not predictive of outcome, and therefore asymptomatic patients should not be deferred from stress testing. A normal study identifies a very low-risk population in whom no further intervention is required.
引用
收藏
页码:615 / 622
页数:8
相关论文
共 50 条
  • [1] Risk stratification of patients after myocardial revascularization by stress Tc-99m tetrofosmin myocardial perfusion tomography
    Abdou Elhendy
    Arend F. L. Schinkel
    Ron T. van Domburg
    Jeroen J. Bax
    Roelf Valkema
    Don Poldermans
    Journal of Nuclear Cardiology, 2003, 10 : 615 - 622
  • [2] Comparison of Outcome After Myocardial Infarction in Patients With and Without Abnormalities on Previous Stress Tc-99m Tetrofosmin Myocardial Perfusion Imaging
    Elhendy, Abdou
    Schinkel, Arend F. L.
    van Domburg, Ron T.
    Bax, Jeroen J.
    Feringa, Harm H. H.
    Noordzij, Peter G.
    Schouten, Olaf
    Karagiannis, Stefanos E.
    Dunkelgrun, Martin
    Poldermans, Don
    CLINICAL NUCLEAR MEDICINE, 2008, 33 (12) : 852 - 855
  • [3] Prognostic implications of stress Tc-99m tetrofosmin myocardial perfusion imaging in patients with left ventricular hypertrophy
    Abdou Elhendy
    Arend F. L. Schinkel
    Ron T. van Domburg
    Jeroen J. Bax
    Harm H. H. Feringa
    Peter G. Noordzij
    Olaf Schouten
    Don Poldermans
    Journal of Nuclear Cardiology, 2007, 14 : 550 - 554
  • [4] Prognostic implications of stress Tc-99m tetrofosmin myocardial perfusion imaging in patients with left ventricular hypertrophy
    Elhendy, Abdou
    Schinkel, Arend F. L.
    van Domburg, Ron T.
    Bax, Jeroen J.
    Feringa, Harm H. H.
    Noordzij, Peter G.
    Schouten, Olaf
    Poldermans, Don
    JOURNAL OF NUCLEAR CARDIOLOGY, 2007, 14 (04) : 550 - 554
  • [5] Mediastinal thymoma diagnosed with Tc-99m tetrofosmin SPECT myocardial perfusion imaging
    Elsayed Abo-Salem
    Myron Gerson
    Journal of Nuclear Cardiology, 2014, 21 : 1258 - 1259
  • [6] Risk stratification using line source attenuation correction with rest/stress Tc-99m sestamibi SPECT myocardial perfusion imaging
    Afrooz Ardestani
    Alan W. Ahlberg
    Deborah M. Katten
    Krista Santilli
    Donna M. Polk
    Timothy M. Bateman
    Gary V. Heller
    Journal of Nuclear Cardiology, 2014, 21 : 118 - 126
  • [7] Risk stratification using line source attenuation correction with rest/stress Tc-99m sestamibi SPECT myocardial perfusion imaging
    Ardestani, Afrooz
    Ahlberg, Alan W.
    Katten, Deborah M.
    Santilli, Krista
    Polk, Donna M.
    Bateman, Timothy M.
    Heller, Gary V.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2014, 21 (01) : 118 - 126
  • [8] Risk stratification of patients with angina pectoris by stress 99mTc-tetrofosmin myocardial perfusion imaging
    Elhendy, A
    Schinkel, AFL
    van Domburg, RT
    Bax, JJ
    Valkema, R
    Huurman, A
    Feringa, HH
    Poldermans, D
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (12) : 2003 - 2008
  • [9] Pathologic extracardiac uptake of Tc-99m tetrofosmin identified in the chest during myocardial perfusion imaging
    Vani Vijayakumar
    Rajiv Gupta
    Atiar Rahman
    Journal of Nuclear Cardiology, 2005, 12
  • [10] Lung Mass Appearing as a Dilated Left Ventricle on Tc-99m Tetrofosmin Myocardial Perfusion Scintigraphy
    Gnanasegaran, Gopinath
    Williams, Robert
    Mclean, Emma
    O'Connell, Rachel
    Nunan, Thomas O.
    O'Doherty, Michael J.
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (09) : 620 - 621